• About us
• Contact

Advertisement

Product › Details

drug discovery

Record changed: 2025-03-07

Advertisement

More documents for drug discovery

• [1] Insilico Medicine. (3/13/25). "Press Release: Insilico Medicine Secures $110 Million Series E Financing to Advance AI-Driven Drug Discovery Innovation". Cambridge, MA....
• [2] Medigene AG. (2/27/25). "Press Release: Medigene and EpimAb Biotherapeutics Enter into a Co-Development Partnership for TCR-Guided T Cell Engagers". Planegg....
• [3] Enveda. (2/26/25). "Press Release: Enveda Gains Backing from Sanofi to Advance AI-Driven Drug Discovery to Clinical Trials Bringing Total Series C Financing to $150M". Boulder, CO....
• [4] Candid Therapeutics, Inc.. (1/13/25). "Press Release: Candid Therapeutics Enters into Agreement with WuXi Biologics on Trispecific T-cell Engager". New Brunswick, NJ & Bedminster, NJ....
• [5] Innovent Biologics, Inc.. (1/2/25). "Press Release: Innovent Enters into Exclusive Global License Agreement with Roche for Novel DLL3 Antibody Drug Conjugate". San Francisco, CA & Suzhou....
• [6] Enveda. (11/21/24). "Press Release: Enveda Closes $130M Series C Funding to Deliver Multiple Clinical Readouts from a Pipeline of 10 Development Candidates". Boulder, CO....
• [7] |transkript [Kääb, Georg]. (10/21/24). "Miltenyi Biotec: An Exclusive, Rare Interview with Founder Stefan Miltenyi. Interview by |transkript.de/Georg Kääb"....
• [8] Nuclera Ltd.. (10/16/24). "Press Release: Nuclera Closes $75 Million USD Financing > Series C round led by Elevage Medical Technologies". Cambridge & Boston, MA....
• [9] Innovent Biologics, Inc.. (10/8/24). "Press Release: Innovent and Ask Pharm Announce Strategic Collaboration for Limertinib, a Third-generation EGFR TKI for the Treatment of Lung Cancer". San Francisco, CA & Suzhou....
• [10] Yumab GmbH. (10/8/24). "Press Release: Yumab and Molcure Collaborate To Advance Zero-Shot AI Antibody Discovery Technology For Undrugged Targets"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.